UPDATE: GW’s Epidiolex on April 19 received a unanimous recommendation from the Peripheral and Central Nervous System Drugs Advisory Committee of the U.S. Food and Drug Association. The following article has been updated to reflect that decision. This is a make-or-break spring for GW Pharmaceuticals and its billion-dollar investment in a cannabidiol-based drug. The London-based firm aims to develop the first FDA-approved medicine from plant-derived cannabis compounds. The U.S.

BING NEWS:
  • GW Pharma Will Be Acquired by Jazz Pharmaceuticals for $7.2 Billion
    Jazz’s lead product, Epidiolex, is the first plant-derived ... as well as ongoing clinical and research programs," GW Pharmaceuticals CEO Justin Gover said in the statement. “ ...
    02/3/2021 - 2:20 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News